Back to signals
FDA device recallVulnerabilitiesPublished October 23, 2025

Tandem Diabetes Care, Inc.: Alternate Controller Enabled Insulin Infusion Pump

A software defect in versions 7.9.0.1 and 7.10.1 of the pump software for Tandem t:slim X2 and version 7.9.0.1 of the Tandem Mobi pump with Control-IQ+ technology that are paired with a G7 sensor may result in an unexpected automatic insulin correction bolus (autobolus ) which could result in hypoglycemia.

Open the source record
Tags
FDA recall, medical device, class 2, Clinical Chemistry, Software change control, Open, Classified
Related exam domains
CISSP 3: Security Architecture and Engineering; CISSP 8: Software Development Security; CISM 3: Information Security Program
Source record id
Z-0232-2026
First seen by InfoSec Signals
9/23/2026

Exam domain labels come from a keyword heuristic and are study hints, not an official mapping. The summary is the publisher's own text, shortened; the linked record is authoritative.

Tandem Diabetes Care, Inc.: Alternate Controller Enabled Insulin Infusion Pump | InfoSec Signals